SPONSOR
Henan Cancer Hospital
Total Trials
9
Recruiting
9
Phases
Phase 3, Phase 1, Phase 2, Phase 1
Conditions studied: Esophageal CancerSurgeryNeoadjuvant TreatmentSurvivalMetastatic Gastroesophageal Junction AdenocarcinomaNon-small Cell Lung CancerLeptomeningeal MetastasisEGFR Gene MutationRelapsed/Refractory B-cell LymphomasHepatocellular Carcinoma
NCT04280822 Phase 3
Recruiting
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Esophageal Cancer
NCT06329973 Phase 1, Phase 2
Recruiting
Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
Metastatic Gastroesophageal Junction Adenocarcinoma
NCT06643000
Recruiting
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
Non-small Cell Lung Cancer
NCT06478381 Phase 1
Recruiting
L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma
Relapsed/Refractory B-cell Lymphomas
NCT06478927
Recruiting
Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib
Hepatocellular Carcinoma
NCT07057427 Phase 3
Recruiting
Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Breast Cancer
NCT06605521
Recruiting
To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients
Locally Advanced Breast Cancer
NCT05063136 Phase 3
Recruiting
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
Breast Cancer
NCT05596344
Recruiting
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
Malignant Tumor